Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-05-13
2008-05-13
Monshipouri, Maryam (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200, C530S350000, C435S214000, C424S001210
Reexamination Certificate
active
07371722
ABSTRACT:
The invention relates to a pharmaceutically active substance for producing a drug that is capable of generating thrombin or that contains thrombin and compositions comprising thereof. The pharmaceutically active substance contains (A) prothrombin (coagulation factor II) obtained from plasma or by genetic engineering, (B) coagulation factors V, VIII, IX, X obtained from plasma or by genetic engineering that at least partially may be present in their activated state, and coagulation factor XIa obtained from plasma or by genetic engineering, and (C) prion-safe, coagulation-promoting phospholipids, where the phospholipids are optionally contained in liposomes.
REFERENCES:
patent: 4160025 (1979-07-01), Eibl et al.
patent: 4188318 (1980-02-01), Shanbrom
patent: 4286056 (1981-08-01), Andary et al.
patent: 4395396 (1983-07-01), Eibl et al.
patent: 6358534 (2002-03-01), Schwarz et al.
patent: 2005/0192223 (2005-09-01), Eibl
patent: 2156991 (1996-02-01), None
patent: 198 24 306 (1999-11-01), None
patent: 0 680 764 (1995-11-01), None
patent: 0 700 684 (1996-05-01), None
patent: 8102105 (1981-08-01), None
Lammle et al., Clinics in haemotology, 1985, 14(2), 281-342.
European Pharmacopoeia Suppl. 4.5. Jul. 2003, p. 3687.
European Pharmacopoeia (Eur.Pharm.4thEdition 2002, pp. 123-126, 2.6.1. Sterility. pp. 131-132, 2.6.8. Pyrogens.
Blombäck B. Fibrinogen: Evolution of the Structure-Function Concept: Keynote Address at Fibrinogen 2000 Congress. Annals N.Y. Acad.Sci. 2001; 936:1-10.
Booth N.A. TAFI Meets the Sticky Ends. Thromb.Haemost. 2001; 85:1-2.
Siebenlist K.R., Meh D.A., Mosesson M.W. Protransglutaminase (F-XIII) mediated cross-linking of fibrinogen and fibrin. Thromb.Haemost.2001; 86:1221-1228.
Rapaport S.I., Rao, L.V.M. The Tissue Factor Pathyway: How it has become a “Prima Ballerina”. Thromb.Haemost.1995; 74-7-17.
Von dem Borne P.A.K., Koppelman S.J., Bouma B.N. et al. Surface independent factor XI activation by thrombin in the presence of high molecular weight kininogen. Thromb.Haemost.1994; 72:397-402.
Drake T.A., Morrissey J.H., Edgington T.S. Selective cellular expression of tissue factor in human tissue. Implication for disorders of hemostasis and thrombosis. Am.J.Path.1989; 134:1087-1097.
Mann K.G., Jenny R.J., Krishnaswamy. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Ann.Rev.Biochem.1988; 57:915-956.
Matras H. et. Al. Zur Klebung von Nervenanstomosen mit Gerinnungssubstanzen. Fortschr.Kiefer-Gesichts-Chir.1976; 112-114.
Spängler H.P. Gewebeklebung und lokale Blutstillung mit Fibrinogen, Thrombin und Blutgerinnungsfaktor XIII (Experimentelle Untersuchungen und klinische Erfahrungen). Wien.klin.Wschr.1976; 88(4):3-18.
Davie E.W., Ratnoff O.D. Waterfall sequence for intrinsic blood clotting. Science 1964; 145-1310-1312.
MacFarlane R.G. An enzyme cascade in the blood clotting mechanism and its function as a biochemical amplifier. Nature 1964; 202:498-499.
Young F. et al. “Suture” of Wounds by Plasma-Thrombin Adhesion. War Med.1944; 6:80-85.
Grey E.G. Fibrin as a haemostatic in cerebral surgery. Surg. Gyn.Obst.1915; 21-452-445.
Morawitz P. Die Chemie der Blutgerinnung. Ergebn.d.Physiol.1905; 4:307.
Butenas et al., “Normal” Thrombin Generation, Blood, 1999, 94:2169-2178.
Baker & Botts LLP
Bio & Bio Licensing S.A.
Monshipouri Maryam
LandOfFree
Pharmaceutical preparations and medicine capable of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical preparations and medicine capable of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical preparations and medicine capable of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2806594